Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
US FDA guidance explains how to display proprietary and established drug names in promotional material
26 January 2012
Vibha Sharma

The US Food and Drug Administration has issued final guidance for prescription drug manufacturers clarifying how they may display the proprietary and established names of drug products in promotional materials, including advertisements disseminated via social media websites1,2...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36